https://www.invivogen.com/plasmocure
Plasmocure™ is recommended for the eradication of mycoplasmas that appear, in very rare cases, to be resistant to Plasmocin™.
Plasmocure™ is active against various mycoplasma species that infect mammalian cell cultures including M. hyorhinis, M. orale, M. arginini, M. fermentans, M. hominis and Acholeplasma laidlawii.
Plasmocure™ combines two antibiotics that act through different mechanisms than those found in Plasmocin™.
A two-week treatment with Plasmocure™ is usually sufficient to completely eliminate the mycoplasmas.
A moderate toxicity can be observed during the course of the treatment but full recovery of the cell line is expected once mycoplasmas are eliminated.
Product concentration: 100 mg/ml
Elimination of mycoplasmas in two weeks (recommended concentration of 50 μg/ml)
Endotoxin level: < 0.5 EU/mg
Physicochemical characterization: pH and appearance
Cell culture tested: potency validated on bacterial reference strains